EATG » Viral Hepatitis Portfolio

Viral Hepatitis Portfolio

Viral hepatitis (HCV and HBV) remain one of the most important killers of people living with HIV. The EATG has been working in the field of community education and mobilisation, advocacy and policy around viral hepatitis since 2010. A dedicated Hepatitis Coordinator is responsible for making sure that our efforts in this field are concerted and scientifically sound.

The following pages contain various publications, reports and papers produced in the course of the work of the Viral Hepatitis Portfolio.

Overall aim: Improving access to prevention, comprehensive, modern and cost-effective treatment, care and support of viral hepatitis for people living with HIV in Europe and Central Asia


  • To inform the EATG membership about viral hepatitis, its prevention, treatment and care;
  • To actualize and define the viral hepatitis priorities and create a concrete common strategy for EATG;
  • To raise awareness inside and outside EATG in terms of viral hepatitis specific issues and new tendencies;
  • To improve knowledge on viral hepatitis, develop skills and increase capacity of EATG members in advocating for access to viral hepatitis diagnostics and treatment.


  • Education and literacy: organising thematic meetings in order to follow the development in the hepatitis research field, creating a comprehensive toolkit;
  • Community involvement in clinical development;
  • Mobilisation and involvement;
  • Collaboration and visibility: e.g. supporting mobilization of WHO work in the field of hepatitis;
  • Advocacy: facilitating the dialogue among regulators, pharma and community for early access to new treatments.

 Expected outcomes:

  • A toolkit on viral hepatitis diagnostics, treatment, care and literacy, as well as advocacy (including videos, power points, leaflets) will be produced and translated into different languages;
  • Various other publications, reports and position papers will be published;
  • The EATG membership will be well informed and mobilized for working on co-infection with hepatitis as one of the main threats for HIV-positive people today;
  • The number of HIV-activists within the European region, who are familiar with the specific viral hepatitis topics and ready to advocate on the local and regional level with the aim of ensuring access to medical services for those in need will be increased.

Contact person: Giorgio Barbareschi (EATG staff) at

Report from the Sitges VI meeting, 2013

Report from the Sitges VII meeting, 2014

Report from the Sitges VIII meeting, 2015

Report on the case study on access to DAAs in Portugal

Minutes from the Multistakeholder Meeting on Viral Hepatitis, October 2017